检索

期
标题
作者
卷 25, 编号 3 (2023)
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Lyadova M., Fedorinov D., Kuzmina E., Antonova T., Sokolskaya V.
PDF
(Rus)
卷 24, 编号 2 (2022)
Cabozantinib in the treatment of patients with advanced renal cell carcinoma
Volkova M., Turupaev K., Kalinin S.
PDF
(Rus)
卷 24, 编号 2 (2022)
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review
Rykov I., Chubenko V.
PDF
(Rus)
卷 25, 编号 1 (2023)
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.
PDF
(Rus)
卷 25, 编号 1 (2023)
Combination of encorafenib and binimetinib in the treatment of patients with BRAF-mutated advanced melanoma. Case report
Orlova K., Petenko N., Garanina N., Demidov L.
PDF
(Rus)
卷 24, 编号 3 (2022)
Triple-negative breast cancer: new options for systemic targeted therapy. A review
Andreev D., Zavyalov A.
PDF
(Rus)
卷 24, 编号 2 (2022)
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin R.
PDF
(Rus)
卷 23, 编号 4 (2021)
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
PDF
(Rus)
卷 24, 编号 2 (2022)
Creating a story on the pages of a book about diffuse B-large cell lymphoma
Editorial B.
PDF
(Rus)
卷 25, 编号 4 (2023)
Dermatological toxicity in the treatment of malignant tumors in children: A review
Belysheva T., Shatokhina E., Komarova A.
PDF
(Rus)
卷 25, 编号 4 (2023)
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review
Dinikina Y., Zheludkova O., Belogurova M., Spelnikov D., Osipov N., Nikitina I.
PDF
(Rus)
卷 23, 编号 4 (2021)
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy
Editorial B.
PDF
(Rus)
卷 22, 编号 3 (2020)
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Nikitin E., Bialik T., Zaritskii A., Iseber L., Kaplanov K., Lopatkina T., Lugovskaia S., Mukhortova O., Osmanov E., Poddubnaya I., Samoilova O., Stadnik E., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
PDF
(Rus)
卷 17, 编号 4 (2015)
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P., Orlova R., Shkolnik M., Karlov P.
卷 16, 编号 1 (2014)
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.
卷 22, 编号 3 (2020)
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Sekacheva M., Nuriev R., Rozhkov A., Semenkov A., Bagmet N., Boroda A.
PDF
(Rus)
卷 15, 编号 1 (2013)
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
卷 22, 编号 2 (2020)
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.
PDF
(Rus)
卷 16, 编号 3 (2014)
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.
卷 23, 编号 1 (2021)
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.
PDF
(Rus)
卷 21, 编号 4 (2019)
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I., Bialik T., Glonina N., Kalashnikova O., Kaplanov K., Lapin V., Medvedeva N., Mikhailova N., Moiseeva T., Nikitin E., Pospelova T., Stadnik E.
PDF
(Rus)
卷 17, 编号 3 (2015)
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Knyazev R., Poddubnaya I., Barinov V., Bokin I.
卷 16, 编号 1 (2014)
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S., Mamontov K., Manihas G., Antimonik N.
卷 22, 编号 4 (2020)
Multiple myeloma
Mendeleeva L., Votiakova O., Rekhtina I., Osmanov E., Poddubnaya I., Grivtsova L., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
PDF
(Rus)
卷 19, 编号 4 (2017)
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V., Hasanova A., Shkuratova V., Belevich Y., Popova N., Simolina E., Vysockaya V., Dudnikova E., Kravchuk T., Minnabetdinova R., Nekrasova O.
PDF
(Rus)
卷 16, 编号 1 (2014)
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
卷 22, 编号 3 (2020)
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
Ognerubov N., Antipova T., Gumareva G.
PDF
(Rus)
卷 19, 编号 2 (2017)
Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience
Valiev T., Levashov A., Batmanova N., Senzhapova E., Turupaev K., Tomchik U., Aleskerova G.
PDF
(Rus)
卷 19, 编号 2 (2017)
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
PDF
(Rus)
卷 17, 编号 4 (2015)
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.
卷 15, 编号 4 (2013)
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A., Ivanov S.
卷 22, 编号 3 (2020)
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.
PDF
(Rus)
卷 19, 编号 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
PDF
(Rus)
卷 17, 编号 1 (2015)
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E., Kerbikov O., Kulaga E.
卷 23, 编号 3 (2021)
Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation
Gorenkova L., Belousova I., Kravchenko S., Kovrigina A., Sidorova Y., Ryzhikova N., Lepik E., Shneyder T.
PDF
(Rus)
卷 16, 编号 3 (2014)
Modern options in personalized therapy of metastatic cutaneous melanoma
Protsenko S., Novik A., Akhaeva Z., Zhabina A., Imyanitov E., Semenova A.
卷 23, 编号 2 (2021)
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.
PDF
(Rus)
卷 18, 编号 4 (2016)
Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma
Ignatova A.
卷 15, 编号 1 (2013)
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
卷 23, 编号 1 (2021)
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.
PDF
(Rus)
卷 22, 编号 1 (2020)
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I., Al-Radi L., Byalik T., Kaplanov K., Molostvova V., Nikitin E., Pospelova T., Ptushkin V., Samoilova O., Stadnik E., Tumyan G.
PDF
(Rus)
卷 18, 编号 2 (2016)
Prognostic factors in patients with disseminated gastrointestinal stromal tumors
Arkhiri P., Stilidi I., Poddubnaya I., Nered S., Nikulin M., Abu-Khaydar O.
PDF
(Rus)
1 - 42 的 42 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##